02617.HK
TransThera Sciences (Nanjing) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 8.40
−2.95%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.48x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 1.57x
Liquidity & coverage
- Current ratio
- 8.82x
- Quick ratio
- 8.82x
- Cash ratio
- 8.70x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- HKD 980.0M
Cash & dividend
- FCF / debt
- -25.77x
- Cash flow / debt
- -25.75x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026